To sum up, the inhibition of the P2X7 receptor exerted anti-inflammatory and anti-remodeling effects on PAH, suggesting that the P2X7 receptor may be a potential therapeutic target. This evidence concerns the gene P2RX7 and pulmonary arterial hypertension.